Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 12 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Vassiliadis, Themistoklis  [Clear All Filters]
Journal Article
Germanidis, G., Hytiroglou P., Vassiliadis T., & Speletas M. (2018).  Checkpoint modulation in chronic hepatitis B: From hypothesis to approval.. Hepatology. 67(3), 1175-1176.
Theocharidou, E., Giouleme O., Anastasiadis S., Markopoulou A., Pagourelias E., Vassiliadis T., et al. (2019).  Free Cortisol Is a More Accurate Marker for Adrenal Function and Does Not Correlate with Renal Function in Cirrhosis.. Dig Dis Sci. 64(6), 1686-1694.
Zachou, K., Sarantopoulos A., Gatselis N. K., Vassiliadis T., Gabeta S., Stefos A., et al. (2013).  Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat.. World J Hepatol. 5(7), 387-92.
Vassiliadis, T., Mpoumponaris A., Giouleme O., Hatzidakis A., Patsiaoura K., Zezos P., et al. (2009).  Late onset ulcerative colitis complicating a patient with Budd-Chiari syndrome: a case report and review of the literature.. Eur J Gastroenterol Hepatol. 21(1), 109-13.
Germanidis, G., Argentou N., Hytiroglou P., Vassiliadis T., Patsiaoura K., Germenis A. E., et al. (2013).  Liver FOXP3 and PD1/PDL1 Expression is Down-Regulated in Chronic HBV Hepatitis on Maintained Remission Related to the Degree of Inflammation.. Front Immunol. 4, 207.
Pyrpasopoulou, A., Douma S., Vassiliadis T., Chatzimichailidou S., Triantafyllou A., & Aslanidis S. (2011).  Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis.. Rheumatol Int. 31(3), 403-4.
Molyvdas, A., Georgopoulou U., Lazaridis N., Hytiroglou P., Dimitriadis A., Foka P., et al. (2018).  The role of the NLRP3 inflammasome and the activation of IL-1β in the pathogenesis of chronic viral hepatic inflammation.. Cytokine. 110, 389-396.
Athyros, V. G., Giouleme O., Ganotakis E. S., Elisaf M., Tziomalos K., Vassiliadis T., et al. (2011).  Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study.. Arch Med Sci. 7(5), 796-805.
Vassiliadis, T., Mpoumponaris A., Vakalopoulou S., Giouleme O., Gkissakis D., Grammatikos N., et al. (2010).  Spur cells and spur cell anemia in hospitalized patients with advanced liver disease: Incidence and correlation with disease severity and survival.. Hepatol Res. 40(2), 161-70.
Argentou, N., Germanidis G., Hytiroglou P., Apostolou E., Vassiliadis T., Patsiaoura K., et al. (2016).  TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment.. Inflamm Res. 65(5), 355-65.
Sinakos, E., Kountouras D., Koskinas J., Zachou K., Karatapanis S., Triantos C., et al. (2017).  Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.. Br J Haematol. 178(1), 130-136.
Vassiliadis, T., Anagnostis P., Patsiaoura K., Giouleme O., Katsinelos P., Mpoumponaris A., et al. (2009).  Valeriana hepatotoxicity.. Sleep Med. 10(8), 935.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.